Sex | ||||||||||
Male | 22 | 45.5% | 18 | 44.4% | 2 | -- | 1 | 100.0% | 1 | 0.0% |
Female | 12 | 66.7% | 10 | 70.0% | 0 | -- | 2 | 50.0% | 0 | -- |
All phenotypes | ||||||||||
T-cell | 14 | 50.0% | 10 | 50.0% | 2 | -- | 1 | 100.0% | 1 | 0.0% |
B-cell | 18 | 55.6% | 16 | 56.3% | 0 | -- | 2 | 50.0% | 0 | -- |
Unknown lineage | 2 | 50.0% | 2 | 50.0% | 0 | -- | 0 | -- | 0 | -- |
Other | 0 | -- | 0 | -- | 0 | -- | 0 | -- | 0 | -- |
10-Year Survival | ||||||||||
All Cases | 34 | 47.1% | 28 | 45.9% | 2 | -- | 3 | -- | 1 | 0.0% |
Age at diagnosis | ||||||||||
0 - 19 years | 16 | 68.8% | 12 | 66.7% | 2 | -- | 2 | -- | 0 | -- |
20 - 39 years | 5 | -- | 4 | -- | 0 | -- | 0 | -- | 1 | 0.0% |
40 - 59 years | 11 | 24.2% | 10 | 26.7% | 0 | -- | 1 | 0.0% | 0 | -- |
>60 years | 2 | -- | 2 | -- | 0 | -- | 0 | -- | 0 | -- |
Sex | ||||||||||
Male | 22 | 36.4% | 18 | 33.3% | 2 | -- | 1 | -- | 1 | 0.0% |
Female | 12 | 66.7% | 10 | 70.0% | 0 | -- | 2 | -- | 0 | -- |
All phenotypes | ||||||||||
T-cell | 14 | 50.0% | 10 | 50.0% | 2 | -- | 1 | -- | 1 | 0.0% |
B-cell | 18 | 44.4% | 16 | 42.2% | 0 | -- | 2 | -- | 0 | -- |
Unknown lineage | 2 | 50.0% | 2 | 50.0% | 0 | -- | 0 | -- | 0 | -- |
Other | 0 | -- | 0 | -- | 0 | -- | 0 | -- | 0 | -- |